Captivating Synergistic, Dose-Dependent Anticancer Effects of Tumor-Regulation Modulators Chloroquine and Ivermectin Completely Abolished by an Opposing Modulator, Deoxycholic Acid, in Hamster Fibrosarcoma: In Vivo, In Vitro, and Literature Review (2026)

Peer-Reviewed Study · (Pharmaceuticals 2026; see PubMed 41901254 for author list) · 2026

(Pharmaceuticals 2026 et al., 2026: Hamster fibrosarcoma study testing chloroquine 50 mg/kg and ivermectin 5 mg/kg alone and combined, reporting synergistic dose-dependent tumour suppression that was abolished by deoxycholic acid.

Methods: A BHK-21/C13 cell culture was subcutaneously inoculated into Syrian golden hamsters randomly divided into groups (6 animals per group)

n/a (PubMed abstract)

(Pharmaceuticals 2026 et al., 2026: Hamster fibrosarcoma study testing chloroquine 50 mg/kg and ivermectin 5 mg/kg alone and combined, reporting synergistic dose-dependent tumour suppression that was abolished by deoxycholic acid. Study type: Syrian golden hamster fibrosarcoma (BHK-21/C13) in vivo, plus in vitro and literature review. N: 6 animals per group. Country: not established from the retrieved record. Dose: ivermectin 5 mg/kg and chloroquine 50 mg/kg daily for 17 days (route not stated in the abstract). Funder/COI: not established from the record. Comparator: untreated control and single agents. Confidence MEDIUM because only the abstract was read; excerpt is a methods record field cut mid-sentence. Study type: animal.